CHARLES TOWN, W.Va., Oct. 18 /PRNewswire-FirstCall/ -- ReBuilder
Medical Technologies, Inc. (Pink Sheets: RBRM), an emerging medical device
manufacturer founded by world-renowned medical device inventor David B.
Phillips, Ph.D., today announced significant developments in ReBuilder's
customer service organization and facilitation.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
In an age when many companies are outsourcing customer service to
overseas facilities, the Company is establishing an innovative customer-
service system staffed by licensed medical professionals who can provide
exceptional one-on-one telephone customer service to both potential and
current customers.
The company has named Carol Faircloth, LPN, to oversee the organization
and development of this new customer-service initiative. She will take on
the task of recruiting and training the additional employees who are needed
to fulfill ReBuilder's expanded customer service initiative. Faircloth
brings a wealth of medical knowledge and customer service experience to the
ReBuilder team. She spent the last 27 years of her career as a Licensed
Professional Nurse.
By staffing its customer support team with employees who possess
medical backgrounds and providing customers in need with instant access to
licensed physicians, ReBuilder Medical Technologies, Inc., can further
enhance value to its shareholders, and support the expected increase in
customers resulting from its ongoing marketing efforts.
"In our 5 years of marketing the ReBuilder System(R) on the internet
and handling call-in inquiries, we found that when a person calls in and
can speak one-on-one with a medical professional, the closing ratio
increases significantly," said ReBuilder CEO, David B. Phillips, Ph.D.
"People today are much more likely to purchase technical equipment if they
can discuss the proposed purchase with a knowledgeable and qualified
representative," said Phillips.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of medical
devices and innovative technologies founded by world-renowned medical
device inventor David B. Phillips, Ph.D. The company's flagship product is
its FDA registered ReBuilder System(R), used for treating peripheral
neuropathy. Unlike current therapies for neuropathy (nerve disease) that
depend on prescription drugs with powerful side effects, the ReBuilder
System(R) is a portable, battery- powered medical product that provides a
unique, non-surgical treatment which is non-invasive, has no side effects
and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips
Molluscum Treatment System(TM) for treating the skin disease Molluscum
Contagiosum which primarily affects children. This system uses its
proprietary form of micronized amorphous silver ions to disable the
molluscum pathogen without side effects. The company is currently
performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV.
CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first
infrared ear thermometer. Dr. Phillips also was responsible for the GST
System, which is used for the early detection of breast cancer, and the
AcuPen, a hand-held device that provides the benefits of acupuncture
without the use of needles.
More information on ReBuilder Medical Technologies, Inc. and its
products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which
are intended to be covered by the safe harbors created thereby. Investors
are cautioned that all forward-looking statements involve risks and
uncertainty, including without limitation, the ability of the Company to
successfully implement its turnaround strategy, changes in costs of raw
materials, labor, and employee benefits, as well as general market
conditions, competition and pricing. Although the Company believes that the
assumptions underlying the forward-looking statements contained herein are
reasonable, any of the assumptions could be inaccurate, and therefore,
there can be no assurance that the forward-looking statements included in
this letter will prove to be accurate. In light of the significant
uncertainties inherent in the forward- looking statements included herein,
the inclusion of such information should not be regarded as representation
by the Company or any other person that the objectives and plans of the
Company will be achieved. In assessing forward- looking statements included
herein, readers are urged to carefully read those statements. When used in
the Annual Report on Form 10-K, the words "estimate," "anticipate,"
"expect," "believe," and similar expressions are intended to be
forward-looking statements.
|
